Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb;82(2):e24.
doi: 10.1016/j.jinf.2020.09.005. Epub 2020 Sep 12.

The association between corticosteroid uses and mortality among severe COVID-19 patients

Hung-Jen Tang  1 , Chih-Cheng Lai  2
Affiliations
Comment

The association between corticosteroid uses and mortality among severe COVID-19 patients

Hung-Jen Tang et al. J Infect. 2021 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Association Between Corticosteroids and 28-Day All-Cause Mortality After Excluding RECOVERY Trial.
See this image and copyright information in PMC

Comment on

References

    1. Yang Z., Liu J., Zhou Y., Zhao X., Zhao Q., Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect. 2020;81:e13–e20. - PMC - PubMed
    1. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Sterne J.A.C., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020 doi: 10.1001/jama.2020.17023. Online ahead of print. - DOI - PMC - PubMed
    1. RECOVERY Collaborative Group. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. NEJMoa2021436Online ahead of print. - DOI - PMC - PubMed
    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55 - PMC - PubMed

Substances